Edgewise Therapeutics Inc (EWTX) Insider Trading
- $36,345,942.77
- $21,522,375.15
- Aug. 26, 2025
- Alan J Russell
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 26, 2025 | Insider | 100,000 | $14.60 | Sell | $1,460,000.00 | |
Aug. 12, 2025 | CFO | 1,428 | $13.39 | Sell | $19,120.92 | |
Aug. 12, 2025 | CEO | 7,972 | $13.39 | Sell | $106,745.08 | |
Aug. 12, 2025 | General Counsel | 2,098 | $13.39 | Sell | $28,092.22 | |
Aug. 12, 2025 | CMO | 2,862 | $13.39 | Sell | $38,322.18 | |
Aug. 12, 2025 | Insider | 1,907 | $13.39 | Sell | $25,534.73 | |
May 2, 2025 | CFO | 1,314 | $16.45 | Sell | $21,615.30 | |
May 2, 2025 | Insider | 1,551 | $16.45 | Sell | $25,513.95 | |
May 2, 2025 | CMO | 5,187 | $16.45 | Sell | $85,326.15 | |
May 2, 2025 | General Counsel | 1,930 | $16.45 | Sell | $31,748.50 | |
May 2, 2025 | CEO | 4,276 | $16.45 | Sell | $70,340.20 | |
April 3, 2025 | Director | 496,771 | $20.13 | Buy | $10,000,000.23 | |
Feb. 6, 2025 | Insider | 1,200 | $30.13 | Sell | $36,156.00 | |
Feb. 5, 2025 | CEO | 8,636 | $30.03 | Sell | $259,339.08 | |
Jan. 28, 2025 | CMO | 25,000 | $27.63 | Sell | $690,750.00 | |
Dec. 30, 2024 | Insider | 100,000 | $27.37 | Sell | $2,737,000.00 | |
Dec. 24, 2024 | Insider | 29,709 | $29.69 | Sell | $882,060.21 | |
Sept. 23, 2024 | General Counsel | 20,922 | $27.63 | Sell | $578,074.86 | |
Sept. 20, 2024 | General Counsel | 50,000 | $28.37 | Sell | $1,418,500.00 | |
Sept. 20, 2024 | CMO | 7,162 | $28.29 | Sell | $202,612.98 | |
Sept. 20, 2024 | CFO | 125,092 | $28.57 | Sell | $3,573,878.44 | |
Sept. 20, 2024 | Insider | 75,000 | $28.27 | Sell | $2,120,250.00 | |
May 2, 2024 | Insider | 1,718 | $18.91 | Sell | $32,487.38 | |
May 2, 2024 | CFO | 2,157 | $18.91 | Sell | $40,788.87 | |
May 2, 2024 | CEO | 3,152 | $18.91 | Sell | $59,604.32 | |
May 2, 2024 | General Counsel | 1,956 | $18.91 | Sell | $36,987.96 | |
May 2, 2024 | CMO | 3,682 | $18.91 | Sell | $69,626.62 | |
Feb. 9, 2024 | General Counsel | 8,029 | $20.01 | Sell | $160,660.29 | |
Feb. 8, 2024 | Insider | 4,600 | $20.01 | Sell | $92,046.00 | |
Feb. 7, 2024 | General Counsel | 17,993 | $20.00 | Sell | $359,860.00 | |
Jan. 23, 2024 | CFO | 90,000 | $15.78 | Sell | $1,420,200.00 | |
Jan. 23, 2024 | Director | 454,545 | $11.00 | Buy | $4,999,995.00 | |
Dec. 27, 2023 | General Counsel | 8,497 | $10.50 | Sell | $89,218.50 | |
Dec. 26, 2023 | Insider | 172,585 | $9.33 | Sell | $1,610,218.05 | |
Dec. 26, 2023 | Director | 10,857 | $9.30 | Buy | $100,970.10 | |
May 2, 2023 | CFO | 1,336 | $8.90 | Sell | $11,890.40 | |
May 2, 2023 | Insider | 1,747 | $8.90 | Sell | $15,548.30 | |
May 2, 2023 | CMO | 3,254 | $8.90 | Sell | $28,960.60 | |
May 2, 2023 | CEO | 3,203 | $8.90 | Sell | $28,506.70 | |
May 2, 2023 | General Counsel | 1,897 | $8.90 | Sell | $16,883.30 | |
Oct. 3, 2022 | General Counsel | 4,730 | $9.76 | Sell | $46,164.80 | |
Sept. 16, 2022 | Director | 484,496 | $10.32 | Buy | $4,999,998.72 | |
Sept. 14, 2022 | Major Shareholder | 484,496 | $10.32 | Buy | $4,999,998.72 | |
Aug. 3, 2022 | General Counsel | 9,232 | $9.31 | Sell | $85,949.92 | |
July 5, 2022 | General Counsel | 8,186 | $8.35 | Sell | $68,353.10 | |
June 21, 2022 | General Counsel | 31,078 | $7.29 | Sell | $226,558.62 | |
June 17, 2022 | General Counsel | 22,127 | $6.62 | Sell | $146,480.74 | |
June 14, 2022 | General Counsel | 3,628 | $6.02 | Sell | $21,840.56 | |
June 10, 2022 | General Counsel | 7,125 | $6.05 | Sell | $43,106.25 | |
June 7, 2022 | General Counsel | 18,123 | $6.61 | Sell | $119,793.03 |
Insiders are both buying and selling Edgewise Therapeutics Inc stock.
The insider traders at Edgewise Therapeutics Inc are: Alan J Russell, John R Moore, R Michael Carruthers, Joanne M Donovan, Kevin Koch, John R. Moore, Behrad Derakhshan, Peter A Thompson, Orbimed Advisors Llc, Holdings A/S Novo, Jonathan C Fox, James E Flynn, Marc Semigran, and Jonathan D Root
The most active insider trader at Edgewise Therapeutics Inc is Alan J Russell with 20 trades.
Alan J Russell has sold the most Edgewise Therapeutics Inc stock with a total value of $11,582,055.27.
Orbimed Advisors Llc has bought the most Edgewise Therapeutics Inc stock with a total value of $20,994,980.46.
The most recent insider trade for Edgewise Therapeutics Inc was on Aug. 26, 2025.
The single biggest insider buy for Edgewise Therapeutics Inc was from Orbimed Advisors Llc with a total value of $10,000,000.23 on April 3, 2025.
The single biggest insider sell for Edgewise Therapeutics Inc was from R Michael Carruthers with a total value of $3,573,878.44 on Sept. 20, 2024.